Prognostic significance of plasma osteopontin in patients with locally advanced head and neck squamous cell carcinoma (HNSCC) treated with chemoradiation on TROG 02.02 phase III trial.
A. M. L. Lim
No relevant relationships to disclose
D. Rischin
No relevant relationships to disclose
H. Cao
No relevant relationships to disclose
R. Fisher
No relevant relationships to disclose
G. A. McArthur
No relevant relationships to disclose
L. J. Peters
No relevant relationships to disclose
R. J. Young
No relevant relationships to disclose
Q. Le
No relevant relationships to disclose